Byram W. Bridle Department of Pathobiology University of Guelph Biography Publications Institution JoVE Articles Byram W. Bridle has not added a biography. If you are Byram W. Bridle and would like to personalize this page please email our Author Liaison for assistance. Publications The Role of Type I Interferon Signaling in Regulating Cytokine Production and Cell Survival in Bone Marrow-Derived Macrophages Viral Immunology. Jun, 2021 | Pubmed ID: 34097550 Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils International Journal of Molecular Sciences. Apr, 2021 | Pubmed ID: 33946935 Combining Vanadyl Sulfate with Newcastle Disease Virus Potentiates Rapid Innate Immune-mediated Regression with Curative Potential in Murine Cancer Models Molecular Therapy Oncolytics. Mar, 2021 | Pubmed ID: 33614913 Type I Interferon α/β Receptor-Mediated Signaling Negatively Regulates Antiviral Cytokine Responses in Murine Bone-Marrow-Derived Mast Cells and Protects the Cells from Virus-Induced Cell Death International Journal of Molecular Sciences. Nov, 2020 | Pubmed ID: 33261178 AAV Vectored Immunoprophylaxis for Filovirus Infections Tropical Medicine and Infectious Disease. Nov, 2020 | Pubmed ID: 33182447 Tumour Vasculature: Friend or Foe of Oncolytic Viruses? Cytokine & Growth Factor Reviews. 12, 2020 | Pubmed ID: 32893095 Enhanced Immunotherapeutic Profile of Oncolytic Virus-based Cancer Vaccination Using Cyclophosphamide Preconditioning Journal for Immunotherapy of Cancer. 08, 2020 | Pubmed ID: 32792361 Optimized Pre-Clinical Grade Production of Two Novel Lentiviral Vector Pseudotypes for Lung Gene Delivery Human Gene Therapy. 04, 2020 | Pubmed ID: 32000531 Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination Methods in Molecular Biology (Clifton, N.J.). 2020 | Pubmed ID: 31486039 AAV-mediated Expression of 3TSR Inhibits Tumor and Metastatic Lesion Development and Extends Survival in a Murine Model of Epithelial Ovarian Carcinoma Cancer Gene Therapy. 05, 2020 | Pubmed ID: 31160686 SR9009 Administered for One Day After Myocardial Ischemia-reperfusion Prevents Heart Failure in Mice by Targeting the Cardiac Inflammasome Communications Biology. 2019 | Pubmed ID: 31602405 Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies Molecular Therapy. Methods & Clinical Development. Sep, 2019 | Pubmed ID: 31388514 Myeloid Cells During Viral Infections and Inflammation Viruses. 02, 2019 | Pubmed ID: 30791481 Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies Molecular Therapy. Methods & Clinical Development. Jun, 2019 | Pubmed ID: 30788384 Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 03, 2019 | Pubmed ID: 30206160 Development and Applications of Oncolytic Maraba Virus Vaccines Oncolytic Virotherapy. 2018 | Pubmed ID: 30538968 Use of Precision-Cut Lung Slices As an Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy Molecular Therapy. Methods & Clinical Development. Sep, 2018 | Pubmed ID: 30112421 Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer Molecular Therapy. Methods & Clinical Development. Jun, 2018 | Pubmed ID: 29556508 Critical Interactions Between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies Journal of Immunology (Baltimore, Md. : 1950). 01, 2018 | Pubmed ID: 29311387 Maraba Virus-vectored Cancer Vaccines Represent a Safe and Novel Therapeutic Option for Cats Scientific Reports. Nov, 2017 | Pubmed ID: 29146945 Immune Responses in the Thyroid Cancer Microenvironment: Making Immunotherapy a Possible Mission Endocrine-related Cancer. 12, 2017 | Pubmed ID: 28912377 Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections Scientific Reports. 08, 2017 | Pubmed ID: 28814733 Metabolic Reprogramming in the Tumour Microenvironment: a Hallmark Shared by Cancer Cells and T Lymphocytes Immunology. 10, 2017 | Pubmed ID: 28621843 Replication and Oncolytic Activity of an Avian Orthoreovirus in Human Hepatocellular Carcinoma Cells Viruses. 04, 2017 | Pubmed ID: 28441762 Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination Journal of Immunology (Baltimore, Md. : 1950). Jun, 2016 | Pubmed ID: 27183620 Maraba Virus As a Potent Oncolytic Vaccine Vector Molecular Therapy : the Journal of the American Society of Gene Therapy. Feb, 2014 | Pubmed ID: 24322333 Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine Molecular Therapy : the Journal of the American Society of Gene Therapy. Sep, 2012 | Pubmed ID: 22760544 Steering Orally Induced Deviation of Xenogeneic Immunity with Exogenous Cytokines in Rats Fed Porcine Proteins Transplant Immunology. Dec, 2009 | Pubmed ID: 19748586 Deviation of Xenogeneic Immune Response and Bystander Suppression in Rats Fed Porcine Blood Mononuclear Cells Transplant Immunology. Jun, 2007 | Pubmed ID: 17493529 T Lymphocyte Subpopulations Diverge in Commercially Raised Chickens Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire. Jul, 2006 | Pubmed ID: 16850940 Rat Genotype Influences Quantitative and Qualitative Aspects of Xenogeneic Immune Response to Pig Blood Mononuclear Cells Xenotransplantation. Jul, 2006 | Pubmed ID: 16768723 Production de vecteurs de virus adéno-associés dans des piles cellulaires pour des études précliniques dans de grands modèles animaux Amira D. Rghei1, Brenna A. Y. Stevens*1, Sylvia P. Thomas*1, Jacob G. E. Yates*1, Benjamin M. McLeod1, Khalil Karimi1, Leonardo Susta1, Byram W. Bridle1, Sarah K. Wootton1 1Department of Pathobiology, University of Guelph JoVE 62727 Immunology and Infection
Production de vecteurs de virus adéno-associés dans des piles cellulaires pour des études précliniques dans de grands modèles animaux Amira D. Rghei1, Brenna A. Y. Stevens*1, Sylvia P. Thomas*1, Jacob G. E. Yates*1, Benjamin M. McLeod1, Khalil Karimi1, Leonardo Susta1, Byram W. Bridle1, Sarah K. Wootton1 1Department of Pathobiology, University of Guelph JoVE 62727 Immunology and Infection